Cargando…

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) and its progressive form nonalcoholic steatohepatitis (NASH) comprise a spectrum of chronic liver diseases in the global population that can lead to end-stage liver disease and hepatocellular carcinoma (HCC). NAFLD is closely linked to the metabolic syndrome,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puengel, Tobias, Liu, Hanyang, Guillot, Adrien, Heymann, Felix, Tacke, Frank, Peiseler, Moritz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910763/ https://www.ncbi.nlm.nih.gov/pubmed/35269812 http://dx.doi.org/10.3390/ijms23052668

Ejemplares similares

Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
por: Peiseler, Moritz, et al.
Publicado: (2021)

The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological data
por: Chen, Shuai, et al.
Publicado: (2022)

The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
por: Kohlhepp, Marlene Sophia, et al.
Publicado: (2023)

Cholangiokines: undervalued modulators in the hepatic microenvironment
por: Cai, Xiurong, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation
por: Chen, Ling-zi, et al.
Publicado: (2021)

Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations
por: Rezvani, Milad, et al.
Publicado: (2023)

Deciphering the Immune Microenvironment on A Single Archival Formalin-Fixed Paraffin-Embedded Tissue Section by An Immediately Implementable Multiplex Fluorescence Immunostaining Protocol
por: Guillot, Adrien, et al.
Publicado: (2020)

Liver Macrophages: Old Dogmas and New Insights
por: Guillot, Adrien, et al.
Publicado: (2019)

Bariatric Surgery Associates with Nonalcoholic Steatohepatitis/Hepatocellular Carcinoma Amelioration via SPP1 Suppression
por: Chen, Shuai, et al.
Publicado: (2022)

Nuclear Receptors in Nonalcoholic Fatty Liver Disease
por: López-Velázquez, Jorge A., et al.
Publicado: (2012)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis
por: Pedersen, Julie Steen, et al.
Publicado: (2020)

Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo
por: Tacke, Frank
Publicado: (2012)

Hepatic C-X-C chemokine receptor type 6–expressing innate lymphocytes limit detrimental myeloid hyperactivation in acute liver injury
por: Heymann, Felix, et al.
Publicado: (2023)

Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
por: Bruneau, Alix, et al.
Publicado: (2021)

Somatic mutant clone screening: scan for novel NASH target genes in mouse liver
por: Lan, Tian, et al.
Publicado: (2023)

Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease
por: Rugivarodom, Manus, et al.
Publicado: (2022)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease
por: Małecki, Paweł, et al.
Publicado: (2020)

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
por: Younossi, Zobair M., et al.
Publicado: (2021)

Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
por: Puengel, Tobias, et al.
Publicado: (2017)

Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue
por: Petrescu, Maria, et al.
Publicado: (2022)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Role of IL-17 and Th17 Cells in Liver Diseases
por: Hammerich, Linda, et al.
Publicado: (2011)

The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Almeda-Valdes, Paloma, et al.
Publicado: (2015)

Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Nakano, Masakazu, et al.
Publicado: (2013)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis
por: Kang, Seong Hee, et al.
Publicado: (2023)

Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression
por: Laschtowitz, Alena, et al.
Publicado: (2023)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
por: Mikolasevic, Ivana, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021)

Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease
por: Cast, Ashley, et al.
Publicado: (2019)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Association between Smoking and Liver Fibrosis among Patients with Nonalcoholic Fatty Liver Disease
por: Ou, Hongjie, et al.
Publicado: (2019)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
por: Soon, Gwyneth, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease
por: Kawamura, Nobuyoshi, et al.
Publicado: (2022)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease—Is There a Link?
por: Orlić, L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_399gv7hjq8rp2i1doni6i568l0